Jennifer Tome Higa Joins the Department of Medicine at Fox Chase Cancer Center

PHILADELPHIA (August 15, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Jennifer Tome Higa, MD, as an interventional gastroenterologist in the Department of Medicine.

Most recently, Higa completed successive fellowships in gastroenterology and advanced endoscopy at the University of Washington and Virginia Mason Medical Center, respectively.

Higa earned her medical degree from the New York Medical College and completed her internship and residency in internal medicine at the Beth Israel Deaconess Medical Center at Harvard Medical School.

“We’re very excited to have Dr. Higa join our team,” said David Weinberg, MD, MSc, chair of the department of medicine at Fox Chase. “Her combination of clinical expertise and research capability will make her an excellent fit at Fox Chase.”

The gastroenterology team at Fox Chase is nationally recognized for its expertise in high-end endoscopic procedures, and its efforts to develop novel endoscopic approaches to complex gastrointestinal disorders. Patients have access to endoscopic procedures that are frequently not available at other medical centers. 

Higa will begin seeing patients at Fox Chase in August.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427